Pain Away Pain Reliever/Fever Reducer Drug Recall for cGMP Deviations
Ultra Seal Corporation is recalling 1,186,000 packets of Pain Away Pain Reliever/Fever Reducer nationwide due to manufacturing practice deviations. The recall was initiated by the firm on a voluntary basis.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for cGMP deviations, a manufacturing process issue. No illnesses, injuries, or deaths are reported in the source text, and the hazard is manufacturing-related rather than an imminent safety threat, making this a moderate-severity precautionary recall.
Plain-English summary
Ultra Seal Corporation is recalling 1,186,000 packets of Pain Away Pain Reliever/Fever Reducer (acetaminophen 110 mg, aspirin 162 mg, salicylamide 152 mg, caffeine 32.4 mg) nationwide within the United States. The recalled product consists of 2 tablets per packet, manufactured for Respond Industries and American First Aid, Mason, Ohio.
The recall was initiated on January 24, 2022, due to cGMP (current Good Manufacturing Practice) deviations. The firm voluntarily initiated this recall. The affected lot is #AK9493 with expiration date 02/2022.
Consumers who have purchased this product should stop using it. The FDA classified this recall as Class II on January 31, 2022. The recall was terminated on October 16, 2023.
The recalled product
- Product
- Pain Away Pain Reliever/Fever Reducer (NSAID) (acetaminophen 110 mg, aspirin 162 mg, salicylamide 152mg, caffeine 32.4 mg), 2 tablets per packet, Mfg, for Respond Industries and American First Aid, Mason, OH 45040
- Manufacturer
- Ultra Seal Corporation
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AK9493
- Exp. Date 02/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- ModerateTopCare Earwax Removal Kit Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22